Individual Complaints Fail to Support Mirapex Fraud Claims, Judge Says

MINNEAPOLIS - General allegations that Mirapex manufacturers committed fraud when they submitted their initial product label to the FDA are sufficiently pled, a federal judge has ruled; however, similar claims asserted by individual plaintiffs may need additional support if they are to proceed. In re Mirapex Products Liability Litigation, MDL No. 07-1836 (D. Minn.).

Judge James M. Rosenbaum of the U.S. District Court for the District of Minnesota ruled Nov. 9 that the plaintiffs' allegations, when backed by information they collectively filed under seal, are sufficient to support claims that the manufacturers deliberately downplayed the compulsive gambling risks associated with …